Literature DB >> 18371982

Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis.

Urszula Ledzewicz1, Heinz Schättler.   

Abstract

Tumor anti-angiogenesis is a cancer treatment approach that aims at preventing the primary tumor from developing its own vascular network needed for further growth. In this paper the problem of how to schedule an a priori given amount of angiogenic inhibitors in order to minimize the tumor volume is considered for three related mathematical formulations of a biologically validated model developed by Hahnfeldt et al. [1999. Tumor development under angiogenic signalling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. Cancer Res. 59, 4770-4775]. Easily implementable piecewise constant protocols are compared with the mathematically optimal solutions. It is shown that a constant dosage protocol with rate given by the averaged optimal control is an excellent suboptimal protocol for the original model that achieves tumor values that lie within 1% of the theoretically optimal values. It is also observed that the averaged optimal dose is decreasing as a function of the initial tumor volume.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18371982     DOI: 10.1016/j.jtbi.2008.02.014

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  12 in total

1.  Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics.

Authors:  Urszula Ledzewicz; Mohammad Naghnaeian; Heinz Schättler
Journal:  J Math Biol       Date:  2011-05-08       Impact factor: 2.259

2.  Building Mathematical Models for Vascular Growth and Inhibition.

Authors:  Fernanda Vieira Berti; Luismar Marques Porto
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Cancer models, genomic instability and somatic cellular Darwinian evolution.

Authors:  Mark P Little
Journal:  Biol Direct       Date:  2010-04-20       Impact factor: 4.540

Review 4.  Mathematical modeling as a tool for planning anticancer therapy.

Authors:  Andrzej Swierniak; Marek Kimmel; Jaroslaw Smieja
Journal:  Eur J Pharmacol       Date:  2009-10-13       Impact factor: 4.432

5.  Angiogenesis and chemotherapy resistance: optimizing chemotherapy scheduling using mathematical modeling.

Authors:  Mariusz Bodzioch; Piotr Bajger; Urszula Foryś
Journal:  J Cancer Res Clin Oncol       Date:  2021-05-29       Impact factor: 4.553

6.  Computational modeling of tumor response to vascular-targeting therapies--part I: validation.

Authors:  Jana L Gevertz
Journal:  Comput Math Methods Med       Date:  2011-03-23       Impact factor: 2.238

7.  Therapeutic implications from sensitivity analysis of tumor angiogenesis models.

Authors:  Jan Poleszczuk; Philip Hahnfeldt; Heiko Enderling
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

8.  Capturing the Driving Role of Tumor-Host Crosstalk in a Dynamical Model of Tumor Growth.

Authors:  Sebastien Benzekry; Afshin Beheshti; Philip Hahnfeldt; Lynn Hlatky
Journal:  Bio Protoc       Date:  2015-11-05

9.  Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan.

Authors:  Gauthier Bouche; Nicolas André; Shripad Banavali; Frank Berthold; Alfredo Berruti; Guido Bocci; Giovanni Brandi; Ugo Cavallaro; Saviero Cinieri; Marco Colleoni; Giuseppe Curigliano; Teresa Di Desidero; Alexandru Eniu; Nicola Fazio; Robert Kerbel; Lisa Hutchinson; Urszula Ledzewicz; Elisabetta Munzone; Eddy Pasquier; O Graciela Scharovsky; Yuval Shaked; Jaroslav Stěrba; Martin Villalba; Francesco Bertolini
Journal:  Ecancermedicalscience       Date:  2014-09-09

10.  Deterministic and Stochastic Study for a Microscopic Angiogenesis Model: Applications to the Lewis Lung Carcinoma.

Authors:  Marek Bodnar; Pilar Guerrero; Ruben Perez-Carrasco; Monika J Piotrowska
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.